These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 19409030)
21. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder. Ketter TA J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635 [TBL] [Abstract][Full Text] [Related]
22. [Therapy of bipolar affective illnesses with valproate. A review of the literature]. Retzow A; Emrich HM Psychiatr Prax; 1998 Jul; 25(4):163-71. PubMed ID: 9738242 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics, drug interactions, and tolerability of valproate. DeVane CL Psychopharmacol Bull; 2003; 37 Suppl 2():25-42. PubMed ID: 14624231 [TBL] [Abstract][Full Text] [Related]
24. Quetiapine in the treatment of acute mania: target dose for efficacious treatment. Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403 [TBL] [Abstract][Full Text] [Related]
25. Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis. Cipriani A; Rendell J; Geddes JR J Psychopharmacol; 2010 Dec; 24(12):1729-38. PubMed ID: 19828571 [TBL] [Abstract][Full Text] [Related]
26. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics. Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520 [TBL] [Abstract][Full Text] [Related]
27. Monotherapy with lithium or valproate or respectively combination therapy with quetiapine have similar effect on cognitive functions in Chinese euthymic patients with bipolar disorder: a cross-sectional survey. Lin Y; Lin Y; Li X; Lao G; Jiang Z; Ye B; Lin W; Liu Y; Cao L J Clin Psychopharmacol; 2013 Dec; 33(6):817-9. PubMed ID: 23963059 [No Abstract] [Full Text] [Related]
28. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder. Calabrese JR; Pikalov A; Streicher C; Cucchiaro J; Mao Y; Loebel A Eur Neuropsychopharmacol; 2017 Sep; 27(9):865-876. PubMed ID: 28689688 [TBL] [Abstract][Full Text] [Related]
29. [Clinical standing of valproate treatment of bipolar disorders]. Grunze H; Adli M; Bauer M; Berger M; Bergmann A; Bräunig P; Bschor T; Falkai P; Gastpar M; Greil W; Kasper S; Krüger S; Laux G; Müller WE; Naber D; Walden J Fortschr Neurol Psychiatr; 2007 Apr; 75(4):220-35. PubMed ID: 17427043 [TBL] [Abstract][Full Text] [Related]
30. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032 [TBL] [Abstract][Full Text] [Related]
31. [Open randomized comparative twelve-week study of lithium and valproate in manic episode]. Mosolov SN; Kostiukova EG; Kapiletti SG; Belen'kaia DV; Shafarenko AA; Fedotov DD Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):47-52. PubMed ID: 20032954 [TBL] [Abstract][Full Text] [Related]
33. Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review. Solomon DA; Keitner GI; Ryan CE; Miller IW J Clin Psychopharmacol; 1998 Feb; 18(1):38-49. PubMed ID: 9472841 [TBL] [Abstract][Full Text] [Related]
34. Disodium valproate: new preparation. An alternative for acute mania after lithium failure or intolerance. Prescrire Int; 2001 Aug; 10(54):113-5. PubMed ID: 11718180 [TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder. Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118 [TBL] [Abstract][Full Text] [Related]
36. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Nasrallah HA; Brecher M; Paulsson B Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884 [TBL] [Abstract][Full Text] [Related]
37. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder. Adler CM; Fleck DE; Brecher M; Strakowski SM J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737 [TBL] [Abstract][Full Text] [Related]
38. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials. Suppes T; Vieta E; Gustafsson U; Ekholm B Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037 [TBL] [Abstract][Full Text] [Related]
39. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). Suppes T; Vieta E; Liu S; Brecher M; Paulsson B; Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454 [TBL] [Abstract][Full Text] [Related]
40. Quetiapine for acute mania in bipolar disorder. Brahm NC; Gutierres SL; Carnahan RM Am J Health Syst Pharm; 2007 May; 64(10):1045-53. PubMed ID: 17494904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]